Stručni studij
HLZ
ESMO RSS
- Unusual or Nonreportable Results from Prenatal cfDNA-Sequencing Suggestive for an Occult Maternal Cancer 13. prosinca 2024.
- Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed or Refractory B-Cell ALL 12. prosinca 2024.
- EMA Recommends Extension of Indications for Pembrolizumab to Malignant Pleural Mesothelioma 11. prosinca 2024.
- FDA Approves Revumenib for Relapsed or Refractory Acute Leukaemia with a KMT2A Translocation 10. prosinca 2024.
- Nivolumab plus Ipilimumab Improves PFS Over Chemotherapy Among Previously Untreated Patients with MSI-H or dMMR mCRC 9. prosinca 2024.